United States - English - NLM (National Library of Medicine)

hong kong prosthodontics medicine limited - glycine (unii: te7660xo1c) (glycine - unii:te7660xo1c) - repair and heal cracked teeth, cracks caused by abrasion, root fissures, etc. do not use when oral infection. it should be cautiously used if you are kind of allergic constitution or you have inflammation. if irritation or discomfort occurs, discontinue the use and consult a physician. apply properly this product on the toothbrush, and brush tooth as like common do.

United States - English - NLM (National Library of Medicine)

hong kong prosthodontics medicine limited - glycine (unii: te7660xo1c) (glycine - unii:te7660xo1c) - stop bleeding gums, reduce swelling, elimnates plague, etc. do not use when oral infection. it should be cautiously used if you are kind of allergic constitution or you have inflammation. if irritation or discomfort occurs, discontinue the use and consult a physician. apply properly this product on the toothbrush, and brush tooth as like common do.

Australia - English - Department of Health (Therapeutic Goods Administration)

well herb pty ltd - lonicera japonica, quantity: 200 mg; glycyrrhiza uralensis, quantity: 12.5 mg (equivalent: glycyrrhiza uralensis, qty 100 mg); schizonepeta tenuifolia, quantity: 10 mg (equivalent: schizonepeta tenuifolia, qty 80 mg); forsythia suspensa, quantity: 25 mg (equivalent: forsythia suspensa, qty 200 mg); platycodon grandiflorus, quantity: 120 mg; arctium lappa, quantity: 15 mg (equivalent: arctium lappa, qty 120 mg); glycine max, quantity: 12.5 mg (equivalent: glycine max, qty 100 mg); mentha haplocalyx, quantity - tablet, uncoated - excipient ingredients: maize starch; magnesium stearate - traditionally used in chinese medicine to dispel/expel/disperse/clear external/exogenous heat ; traditionally used in chinese medicine to dispel/expel/disperse/clear external/exogenous wind ; traditionally used in chinese medicine to dispel/expel/extinguish/disperse/clear wind-heat ; traditionally used in chinese medicine to decrease/reduce/relieve common cold duration ; traditionally used in chinese medicine to decrease/reduce/relieve symptoms of common colds and flu ; traditionally used in chinese medicine to helps decrease/reduce/relieve mild swelling of the glands associated with common cold ; traditionally used in chinese medicine to decrease/reduce/relieve thirstiness associated with common cold

Australia - English - Department of Health (Therapeutic Goods Administration)

gold coast laboratories pty ltd - foeniculum vulgare, quantity: 62.5 mg; dioscorea villosa, quantity: 7.5 mg (equivalent: dioscorea villosa, qty 75 mg); colecalciferol, quantity: 0.0013 mg; magnesium oxide, quantity: 35.1 mg (equivalent: magnesium, qty 21.17 mg); trifolium pratense, quantity: 200 mg (equivalent: trifolium pratense, qty 800 mg); calcium hydrogen phosphate dihydrate, quantity: 183 mg; glycine max, quantity: 23.5 mg (equivalent: glycine max, qty 3.525 g) - capsule, hard - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; soy polysaccharide; magnesium stearate; silicon dioxide; maize starch; dl-alpha-tocopherol; sucrose; hydrolysed gelatin; hydrogenated soya oil

Australia - English - Department of Health (Therapeutic Goods Administration)

sun herbal pty ltd - arctium lappa, quantity: 21.933 mg (equivalent: arctium lappa, qty 47.475 mg); glycine max, quantity: 21.933 mg (equivalent: glycine max, qty 47.475 mg); forsythia suspensa, quantity: 26.317 mg (equivalent: forsythia suspensa, qty 56.962 mg); glycyrrhiza uralensis, quantity: 10.949 mg (equivalent: glycyrrhiza uralensis, qty 23.7 mg); schizonepeta tenuifolia, quantity: 10.967 mg (equivalent: schizonepeta tenuifolia, qty 23.737 mg); mentha haplocalyx, quantity: 10.967 mg (equivalent: mentha haplocalyx, qty 23.737 mg); lonicera japonica, quantity: 26.317 mg (equivalent: lonicera japonica, qty 56.962 mg); platycodon grandiflorus, quantity: 10.967 mg (equivalent: platycodon grandiflorus, qty 23.737 mg); phragmites australis, quantity: 21.933 mg (equivalent: phragmites australis, qty 47.475 mg); phyllostachys nigra, quantity: 10.967 mg (equivalent: phyllostachys nigra, qty 23.737 mg) - pill - excipient ingredients: soluble maize starch - traditionally used in chinese medicine to remove heat toxin ; traditionally used in chinese medicine to dispel/expel/extinguish/disperse/clear wind-heat

Israel - English - Ministry of Health

remedix care ltd - glycine; l- alanine; l- aspartic acid; l- cysteine; l- glutamic acid; l- isoleucine; l- leucine; l- lysine; l- methionine; l- ornithine hydrochloride; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; taurine - solution for infusion - l- valine 0.76 g / 100 ml; l- tyrosine 0.045 g / 100 ml; l- tryptophan 0.2 g / 100 ml; l- threonine 0.37 g / 100 ml; taurine 0.06 g / 100 ml; l- serine 0.4 g / 100 ml; l- proline 0.3 g / 100 ml; l- phenylalanine 0.42 g / 100 ml; l- ornithine hydrochloride 0.318 g / 100 ml; l- methionine 0.24 g / 100 ml; l- lysine 1.1 g / 100 ml; l- leucine 1.0 g / 100 ml; l- isoleucine 0.67 g / 100 ml; l-histidine 0.38 g / 100 ml; glycine 0.4 g / 100 ml; l- glutamic acid 1.0 g / 100 ml; l- cysteine 0.189 g / 100 ml; l- aspartic acid 0.6 g / 100 ml; l-arginine 0.84 g / 100 ml; l- alanine 0.8 g / 100 ml - lysine - lysine - primene 10 % is indicated in 1) children and infants 2) neonates at term or premature of normal or low birth weight when oral or enteral nutrition is impossible insufficient or contraindicated.משטר מינון: 3/7/2019 שינוי בפרק 4.2 בעלון ללא שינוי ברשיון הנמוקים לבקשה: בהתאם לעלון רפרנס spc-uk ו-clinical overview

Australia - English - Department of Health (Therapeutic Goods Administration)

shen neng herbal medicines group pty ltd - forsythia suspensa, quantity: 29.8 mg (equivalent: forsythia suspensa, qty 164 mg); arctium lappa, quantity: 19.8 mg (equivalent: arctium lappa, qty 109 mg); glycine max, quantity: 12.4 mg (equivalent: glycine max, qty 68 mg); platycodon grandiflorus, quantity: 109 mg (equivalent: platycodon grandiflorus, qty 109 mg); lonicera japonica, quantity: 29.8 mg (equivalent: lonicera japonica, qty 164 mg); glycyrrhiza uralensis, quantity: 12.4 mg (equivalent: glycyrrhiza uralensis, qty 68 mg); peppermint oil, quant - tablet, sugar coated - excipient ingredients: tartrazine; magnesium stearate; carnauba wax; sucrose; brilliant blue fcf; prunus persica; maize starch; dimethicone 12500; purified talc; maltodextrin - traditionally used in chinese medicine to remove heat toxin ; traditionally used in chinese medicine to dispel/expel/disperse/clear external/exogenous wind ; traditionally used in chinese medicine to relieve dry mouth ; traditionally used in chinese medicine to decrease/reduce/relieve headache symptoms ; traditionally used in chinese medicine to decrease/reduce/relieve symptoms of common colds and flu ; traditionally used in chinese medicine to decrease/reduce/relieve cough ; traditionally used in chinese medicine to relieve symptoms of sore throat/pharyngitis

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), histidine (unii: 4qd397987e) (histidine - unii:4qd397987e), isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), alanine (unii: of5p57n2zx) (alanine - unii:of5p57n2zx), glycine (unii: te7660xo1c) (glycine - unii:te7660xo1c), arginine (unii: 94zla3w45f) (arginine - unii:94zla3w45f), proline (unii: 9dlq4ciu6v) (proline - unii:9dlq4ciu6v), glutamic acid (unii: 3kx376gy7l) (glutamic acid - unii:3kx376gy7l), serine (unii: 452vly9402) (serine - unii:452vly9402), aspartic acid (unii: 30kyc7miai) (aspartic acid - unii:30kyc7miai), tyrosine (unii: 42hk56048u) (tyrosine - unii:42hk56048u) - valine 1.44 g in 100 ml - prosol is indicated as a source of amino acids for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. prosol may be used to treat negative nitrogen balance in patients. the use of prosol is contraindicated in: risk summary limited published data with injectable amino acids solutions, including prosol in pregnant women are not sufficient to inform a drug associated risk for adverse developmental outcomes. however, malnutrition in pregnant women is associated with adverse maternal and fetal outcomes [see clinical considerations]. animal reproduction studies have not been conducted with injectable amino acids solutions, including prosol. the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. however, the background risk in the u.s. general population of major birth defects is 2 to 4% and of miscarriage is 15 to 20% of clinically recognized pregnancies. clinical considerations disease-associated maternal and/or embryo-fetal risk severe malnutrition in pregnant women is associated with preterm delivery, low birth weight, intrauterine growth restriction, congenital malformations and perinatal mortality. parenteral nutrition should be considered if a pregnant woman’s nutritional requirements cannot be fulfilled by oral or enteral intake. risk summary there are no data available to assess the presence of injectable amino acids, including prosol in human milk, the effects of prosol on the breastfed infant or the effects on milk production. the lack of clinical data during lactation precludes a clear determination of the risk of prosol to a child during lactation; therefore, the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for prosol and any potential adverse effects on the breastfed child from prosol or from the underlying maternal condition. neonates, especially premature infants with low birth weight, are at increased risk of developing hypo- or hyperglycemia and therefore need close monitoring during treatment with intravenous glucose solutions to ensure adequate glycemic control in order to avoid potential long term adverse effects [see dosage and administration (2.7)]. plasma electrolyte concentrations should be closely monitored in the pediatric patients who may have impaired ability to regulate fluids and electrolytes. hyperammonemia is of special significance in infants (birth to two years). this reaction appears to be related to a deficiency of the urea cycle amino acids of genetic or product origin. it is essential that blood ammonia be measured frequently in infants [see warnings and precautions (5.7)]. because of immature renal function, preterm infants receiving prolonged parenteral nutrition treatment with prosol may be at risk of aluminum toxicity [see warnings and precautions (5.8)]. patients, including pediatric patients, may be at risk for pnald [see warnings and precautions (5.9)]. clinical studies with prosol have not been performed to determine whether subjects aged 65 and over respond differently from other younger subjects. other reported clinical experience has not identified differences in responses between the elderly and younger patients. in general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or drug therapy. in patients with impaired renal function, parenteral nutrition solutions containing prosol should be administered with caution. frequent clinical evaluation and laboratory tests to monitor renal function such as serum electrolytes (especially phosphate and potassium) and fluid balance should be conducted [see dosage and administration (2.6) , and warnings and precautions (5.10)]. in patients with impaired liver function, parenteral nutrition solutions containing prosol should be administered starting at the low end of the dosing range [see dosage and administration (2.5)]. frequent clinical evaluation and laboratory tests to monitor liver function such as bilirubin and liver function parameters should be conducted [see warnings and precautions (5.7) ].

Australia - English - Department of Health (Therapeutic Goods Administration)

cathay herbal laboratories - arctium lappa, quantity: 33.33 mg (equivalent: arctium lappa, qty 399.96 mg); glycine max, quantity: 17.76 mg (equivalent: glycine max, qty 266.4 mg); forsythia suspensa, quantity: 66.72 mg (equivalent: forsythia suspensa, qty 667.2 mg); glycyrrhiza uralensis, quantity: 29.6 mg (equivalent: glycyrrhiza uralensis, qty 266.4 mg; equivalent: sucrose, qty 10 mg; equivalent: glucose monohydrate, qty 10 mg); schizonepeta tenuifolia, quantity: 40 mg (equivalent: schizonepeta tenuifolia, qty 400 mg); mentha haplocalyx, quantity: 16.65 mg (equivalent: mentha haplocalyx, qty 266.4 mg); lonicera japonica, quantity: 51.32 mg (equivalent: lonicera japonica, qty 667.16 mg); lophatherum gracile, quantity: 25 mg (equivalent: lophatherum gracile, qty 400 mg); platycodon grandiflorus, quantity: 40 mg (equivalent: platycodon grandiflorus, qty 400 mg); phragmites australis, quantity: 66.69 mg (equivalent: phragmites australis, qty 1.067 g) - capsule, hard - excipient ingredients: purified water; glycerol; carrageenan; magnesium stearate; ethyl hydroxybenzoate; microcrystalline cellulose - traditionally used in chinese medicine to dispel/expel/extinguish/disperse/clear wind-heat

Philippines - English - FDA (Food And Drug Administration)

avli biocare inc.; distributor: avli biocare inc. - sulfonamides , kaolin , glycine , pectin , hyoscine , minerals (vet.) - suspension - formulation: each 60 ml contains: sulfadiazine..............852mg sulfadimidine............639mg sulfaguanidine................639mg kaolin.................3.10 g glycine.................627mg pectin..................213mg hyoscine...............1.20mg sodium chloride....................340 mg streptomycin sulfate. ........................228 mg potassium chloride.....................109 mg calcium gluconate..............66 mg neomycin sulfate................54 mg magnesium sulfate (as heptahydrate)............ 18 mg